Needham & Company Maintains Bullish View on Sarepta Therapeutic (SRPT) Following Results and Eteplirsen Regulatory Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. DFTX
8. LLY
9. RGNX
10. LCO

Go back to Needham & Company Maintains Bullish View on Sarepta Therapeutic (SRPT) Following Results and Eteplirsen Regulatory Update
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 17.88 +0.35 (2.00%)
Previous Close $17.53    52 Week High $63.73 
Open $17.82    52 Week Low $8.00 
Day High $18.05    P/E N/A 
Day Low $17.50    EPS $-5.69 
Volume 745,435